Petros Pharmaceuticals Launches Two Self-Selection Studies for Erectile Dysfunction Drug STENDRA® (avanafil)

/PRNewswire/ -- Petros Pharmaceuticals, Inc. ("Petros" or "the Company") (Nasdaq: PTPI), a leading provider of therapeutics for men's health, has initiated two...

Related Keywords

,Endo Pharmaceuticals ,Company Nasdaq ,Petros Pharmaceuticals ,Drug Administration ,Exchange Commission ,Petros Pharmaceuticals Inc ,Securities Exchange ,Auxilium Pharmaceuticals ,Prnewswire Petros Pharmaceuticals Inc ,Fady Boctor ,Chief Commercial ,Important Risk Information ,Prescribing Information ,Securities Act ,Securities Exchange Act ,Sarbanes Oxley Act ,Financial Condition ,Nc ,